Abstract
The University Hospital Gent is a tertiary care hospital with 1054 beds. The purpose of this study was to evaluate the in vitro susceptibility of clinically significant Gramnegative isolates from patients, hospitalized in critical care departments, toward different extended spectrum b-lactam antibiotics [cefepime (FEP), ceftazidime (CAZ), cefpirome (CPO), piperacillintazobactam (TZP), ticarcillin-clavulanic acid (TCA), and amoxicillin-clavulanic acid (AUG)] as a means to determine the place of the new antibiotics in the hospital formulary.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
